Beyond small clinical cohorts, large-scale patient outcome data strongly supports the use of these compounds
We detected a lower arginine/proline media ratio (lower metabolite concentrations in arginine medium compared to proline medium) for 2-oxoglutarate, linoleate, 11,14-eicosadienote, proline, 2-aminoadipate, pyroglutamate, para-toluate, 2-aminobutyrate, lysine, glutamine, alanine, glutamate, serine, and margarate in gdh3 / gdh3 mutants compared to wild-type
Personally, I know through genetic testing that I have the SNP (single nucleotide polymorphism) rs1050450(C;T) on my GPX1 gene which reduces my glutathione peroxidase activity and therefore my ability to combat oxidative stress
Mark Hyman FOUNDER, CLEVELAND CLINIC FUNCTIONAL MEDICINE, 16x NYT BESTSELLING AUTHOR, Rho Partner Rho's targeted nutrition and cellular support align perfectly with my functional medicine approach to support healthy aging from the inside out
The authors thank Ms